Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS TrialBen M. Eyck, Ewout W. Steyerberg, Ate van der Gaast et al.|Journal of Clinical Oncology|2021Cited by 788
Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancerJ. Jan B. van Lanschot, Ben M. Eyck, Berend J. van der Wilk et al.|Trials|2021Cited by 91
Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort studyXiaobin Zhang, Ben M. Eyck, Yang Yang et al.|BMC Cancer|2020Cited by 40
The optimal neoadjuvant treatment of locally advanced esophageal cancerBerend J. van der Wilk, J. Jan B. van Lanschot, Ben M. Eyck et al.|Journal of Thoracic Disease|2019Cited by 29
Pattern of recurrence in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancerMarloes Jongh, Bas P. L. Wijnhoven, Ben M. Eyck et al.|BJS Open|2021Cited by 21